CWChristian Weigel

Christian Weigel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christian Weigel has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Karel Kostev

    Department of Gynecology and Obstetrics, University Hospital, Philipps-University Marburg, Baldingerstraße, 35043 Marburg, Germany

    2 shared publications
  • Sven Heiko Loosen

    Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University Düsseldorf, Düsseldorf, Germany

    2 shared publications
  • Tom Luedde

    Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Duesseldorf, Medical Faculty at Heinrich-Heine-University, 40225 Dusseldorf, Germany

    2 shared publications
  • Anselm Kunstein

    Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düesseldorf, Medical Faculty of Heinrich Heine University Düsseldorf, Moorenstraße 5, 40225 Düsseldorf, Germany

    1 shared publication
  • Christoph Roderburg

    Affiliation Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Duesseldorf, Medical Faculty of Heinrich Heine University Duesseldorf, Duesseldorf, Germany

    1 shared publication
  • Christoph Roderburg

    Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Düsseldorf, Germany

    1 shared publication

Latest Publications

  • Open Access

    Twelve‑month rehospitalization after IBD‑related hospitalization in Germany: A retrospective cohort study using administrative hospital data

    by Christian Weigel, Sven H. Loosen, Kaneschka Yaqubi, Petra May, Tom Luedde, Christoph Roderburg, Karel Kostev

    Background/Aims: Rehospitalization is an important indicator of disease burden and healthcare utilization in inflammatory bowel disease (IBD), yet real-world data from Germany remain scarce. This study aimed to describe 12‑month rehospitalization rates after IBD‑related inpatient treatment in Germany and to identify administrative and clinical factors recorded in hospital ICD‑10 coding that are associated with rehospitalization. Methods: In this multicenter retrospective cohort study, anonymized administrative data from 49 German hospitals (Section 21 dataset, 2019–2023) were analyzed. Patients hospitalized with a primary diagnosis of Crohn’s disease (ICD-10 K50) or ulcerative colitis (ICD-10 K51) were included. The primary endpoint was any rehospitalization within 12 months after the index admission. Univariable and multivariable logistic regression models were used to determine factors of rehospitalization. Results: A total of 3,202 patients were included (51.3% Crohn’s disease, 48.7% ulcerative colitis; mean age 44.2 years; 50.1% female). The 12-month rehospitalization rate was 22.6%, with a median time of 92 days (IQR 61–184). Independent factors in adjusted analyses were admission to a surgical department (AOR 1.79), peritoneal adhesions (AOR 1.98), type 2 diabetes mellitus (AOR 1.54), and hypokalemia (AOR 1.30). Age, sex, and IBD subtype showed no association. Conclusion: Using administrative hospital data, we identified several ICD-10–coded comorbidities and treatment characteristics associated with higher rehospitalization rates. These findings highlight subgroups that may benefit from improved post-discharge management, although clinical interpretation is limited by the administrative nature of the dataset.

  • Open Access

    Clinical Trends and Hospital Mortality of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Germany: A Descriptive Analysis Between 2019 and 2023

    by Sven H. Loosen, Christian Weigel, Anselm Kunstein, Peter Minko, Gerald Antoch, Johannes G. Bode, Tom Luedde, Christoph Roderburg, Karel Kostev

    Background/Objectives: The transjugular intrahepatic portosystemic shunt (TIPS) is an established treatment for complications of portal hypertension in patients with liver cirrhosis. While its use has increased and indications have broadened in recent years, recent comprehensive data on patient characteristics, trends, and in-hospital mortality in Germany are lacking. This study aimed to evaluate current clinical patterns and mortality outcomes associated with TIPS. Methods: This nationwide cross-sectional study used anonymized hospital data from the German InEK database between 2019 and 2023. TIPS procedures were identified using relevant OPS codes. Patient demographics, liver cirrhosis stage (Child–Pugh), hepatic encephalopathy grade, comorbid conditions, and in-hospital mortality were analyzed descriptively. Analyses were conducted using SAS 9.4. Results: A total of 12,905 TIPS procedures were documented. Annual case numbers rose from 2180 in 2019 to 2954 in 2023. Most patients were male (66.3%) and aged 60–74 years. Ascites (68.6%) was the most frequent associated diagnosis, followed by variceal bleeding (16.4%) and hepatorenal syndrome (14.9%). The average hospital stay decreased from 19.6 to 16.8 days. Overall in-hospital mortality was 8.5%, increasing with age (13.0% in ≥75 years), Child–Pugh C cirrhosis (14.9%), PCCL grade 4 (17.6%), hepatorenal syndrome (16.7%), and grade 4 hepatic encephalopathy (56.1%). Conclusions: TIPS usage in Germany has increased over the past five years, with a shift toward earlier disease stages. Higher in-hospital mortality in clinically complex patients underscores the importance of careful patient selection and tailored management strategies in high-risk groups.